Moderna soars after Phase 1 data demonstrated that vaccination with mRNA-1273 elicits an immune response Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Moderna (MRNA) up 32% after reporting interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus, from a Phase 1 study led by the National Institute of Allergy and Infectious Disease
s
- Total (TOT) and Occidental Petroleum (OXY) up 8% and 6% respectively after entering into a purchase and sale agreement in order for Total to acquire Anadarko's assets in Africa
- Under Armour (UAA) up 6% after
announcing that Mohamed El-Erian, a board member since 2018, has been appointed lead independent director of the company's board
UP AFTER EARNINGS -
- Sea Limited (SE) up 8%
- Sohu.com (SOHU) up 1%
- Kamada (KMDA) up 1%
LOWER -
- Bluebird Bio (BLUE) down 3% after filing to sell $400M in common stock
- Centric Brands (CTRC) down 48% after voluntarily filing for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York
- ForeScout (FSCT) down 18% after Advent provided notice to the company that it would not be proceeding to consummate the acquisition of Forescout on May 18, as scheduled
- Parateum (TEUM) down 15% after receiving a determination letter from Nasdaq Stock indicating that the company is not in compliance with the requirement that a listed company timely file all required periodic financial reports with the Securities and Exchange Commission
Symbols:
MRNA TOT OXY UAA UA SE SOHU KMDA BLUE CTRC FSCT TEUM Keywords: Fly Intel, Wall Street, Top Stories, Stocks